Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Bioxis Pharmaceuticals logo — #BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine...

Bioxis Pharmaceuticals

#BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine

Founded 2010 France France 28 employees Venture round Total: $2.50M Biotechnology, Medical Devices +1

General Information

Company Name Bioxis Pharmaceuticals
Founded Year 2010
Location France France
Employees 28
Industries Biotechnology, Medical Devices, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Bioxis Pharmaceuticals. To contact Bioxis Pharmaceuticals, visit bioxis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Bioxis Pharmaceuticals compare?

A PDF of Bioxis Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Bioxis Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Bioxis Pharmaceuticals

Bioxis Pharmaceuticals, a France-based company founded in 2010, is making strides in the biotechnology, medical devices, and pharmaceutical industries. Specializing in regenerative medicine, the company aims to transform scientific innovations into medical devices that enhance patient care in dermatology and aesthetic medicine.

The company's innovation prowess is encapsulated in its leading product CYTOSIAL, a dermal filler symbolizing its commitment to surpassing traditional boundaries—as heralded by its slogans: #BeyondInnovation and #DermalFiller. Aimed at fulfilling doctors' needs, Bioxis Pharmaceuticals is strategically positioned in an evolving market with substantial growth potential.

Previous capital infusion includes a substantial €2.50M venture round on 23 September 2016 from investor Juvamed. The last round highlights investor confidence and the company's potential for scalable innovation.

Business keywords: Regenerative Medicine, Medical Device Development, Dermatology, Aesthetic Medicine, Cosmetic Surgery, Innovation in Medicine, Clinical Development, Product Commercialization, ISO 13485 Certification, Ultra-pure Chitosan, Hyaluronic Acid, Pharmaceutical Industry, Healthcare Innovation, Life Sciences Support, Paris Region Life Sciences Cluster

Services & Products

Discovery of Regenerative Products
Development and Production of Medical Devices
Commercialization of Aesthetic and Dermatological Solutions

Target Customers

Doctors Dermatologists Medical Aesthetic Professionals

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €2.50M 1
Juvamed
23 Sep 2016
Convertible Note Undisclosed 1
Waarde Capital
Waarde Capital
01 Apr 2014
Convertible Note Undisclosed 1
Waarde Capital
Waarde Capital
01 Jan 2013
Private Equity Round Undisclosed 1
Waarde Capital
Waarde Capital
01 Aug 2012

Bioxis Pharmaceuticals Alternatives & Competitors

View All Alternatives
Bioxis Pharmaceuticals vs
AG FARMA
AG FARMA Spain

DERMOSMÉTICA MÉDICA

16 employees
Medical Devices, Pharmaceutical
Bioxis Pharmaceuticals vs
KYLYS
KYLYS Switzerland

BIOMOLECULES NOW, FOR YOUR FUTURE

Debt Financing
3 employees
Biotechnology, Life Sciences
Bioxis Pharmaceuticals vs
ABK Biomedical Inc.
ABK Biomedical Inc. Canada

Improving treatment options for patients with hypervascular tumors

Series C
42 employees
Biotechnology, Health Care
View all alternatives

FAQ About Bioxis Pharmaceuticals

#BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine
Bioxis Pharmaceuticals was founded in 2010.
Bioxis Pharmaceuticals is headquartered in France.
Bioxis Pharmaceuticals operates in Biotechnology, Medical Devices and Pharmaceutical. Its work centres on Regenerative Medicine, Medical Device Development, Dermatology and Aesthetic Medicine. Its customers include Doctors, Dermatologists and Medical Aesthetic Professionals.
Bioxis Pharmaceuticals has approximately 28 employees.
Bioxis Pharmaceuticals has completed 4 funding rounds, raising a total of $2.50M. The latest funding stage is Venture round.
Bioxis Pharmaceuticals offers: Discovery of Regenerative Products, Development and Production of Medical Devices, Commercialization of Aesthetic and Dermatological Solutions.
Top alternatives and competitors to Bioxis Pharmaceuticals include AG FARMA, KYLYS, ABK Biomedical Inc., Restoration Robotics, RegenLab France. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bioxis Pharmaceuticals and AG FARMA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Bioxis Pharmaceuticals, https://bouncewatch.com/company/bioxis-pharmaceuticals, updated 16 September 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes